動物性胃食道逆流症の世界市場

動物性胃食道逆流症の世界市場は2030年までに48億米ドルに到達

2024年に32億米ドルと推定される動物性胃食道逆流症の世界市場は、2024～2030年の分析期間においてCAGR 6.7％で成長し、2030年には48億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである治療タイプは、CAGR 7.6%を記録し、分析期間終了時には27億米ドルに達すると予測されます。診断タイプの成長率は、分析期間中CAGR 5.9％と推定されます。

米国市場は8億8,020万米ドルと推定、中国はCAGR 10.7％で成長予測

米国の動物性胃食道逆流症市場は、2024年に8億8,020万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9億9,690万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.6％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の動物性胃食道逆流症市場- 主要動向と促進要因まとめ

動物において胃食道逆流症が懸念されるようになったのはなぜか？

コンパニオンアニマルや家畜における胃食道逆流症（GERD）の有病率の増加は、獣医師やペットの飼い主の間で大きな懸念となっています。食習慣の変化、ペットの肥満率の上昇、ペットの食事の人間化という傾向の高まりにより、動物、特に犬、猫、馬の胃酸逆流症例が増加しています。動物のGERDは下部食道括約筋の弱体化から起こることが多く、放置すると酸の逆流、不快感、長期的な食道損傷を引き起こします。ペットの健康とウェルネスに対する意識の高まりに伴い、GERD症状を管理するための効果的な診断・治療ソリューションに対する需要が急増しています。内視鏡検査や画像診断といった獣医学的診断の進歩により、早期発見と治療成績の向上が可能になりつつあります。さらに、ペットの飼い主は非侵襲的かつ長期的な管理方法を求めるようになっており、特殊な薬、栄養補助食品、生活習慣の改善などの市場をさらに牽引しています。

技術の進歩はGERDの診断と治療にどのような影響を与えているか？

動物用ヘルスケア技術の急速な進歩は、動物の胃食道逆流症の診断と治療に革命をもたらしています。pHモニターシステム、レントゲン撮影、食道内圧測定などの最新の診断ツールは獣医師がGERDを正確に診断し、個々に合った治療計画を立てる能力を高めています。コンパニオンアニマルでは、腹腔鏡下噴門形成術のような低侵襲手術の採用が増加しており、治療成績の向上と回復時間の短縮が図られています。さらに、プロトンポンプ阻害剤（PPI）、H2受容体拮抗剤、プロキネティック製剤などの先進医薬品の開発により、GERD症状に対してより効果的で的を絞った緩和が可能となっています。酸産生を最小限に抑え、消化器系の健康を最適化するよう処方された特殊な食事などの栄養学的進歩も、長期的な疾患管理に重要な役割を果たしています。このような技術的進歩により、GERD治療はより身近で効率的なものとなり、ペットの飼い主と商業的畜産家の両方のニーズに応えるものとなっています。

動物用GERD市場にはどのような課題と機会が存在するか？

有望な成長の見込みがあるにもかかわらず、動物用GERD市場はいくつかの課題に直面しています。この疾患に関する認知度の低さ、治療費の高さ、動物病院間で標準化された治療プロトコルの欠如などです。ペットの飼い主や畜産農家の多くはGERDの症状や長期的な影響について知らないため、過小診断や治療介入の遅れにつながっています。さらに、高度な診断法や長期的な医薬品治療にかかる費用は、一部の飼い主にとっては高額であり、市場への浸透を妨げています。しかし、このような課題は、特にGERDの症状や予防法に関する認識を高めることを目的とした教育的取り組みを通じて、市場成長の大きな機会となります。ペットのホリスティック・ウェルネスと予防ヘルスケアが重視されるようになり、胃腸の健康をサポートするプロバイオティクス・サプリメント、天然消化補助食品、機能性食品の需要が高まっています。さらに、動物用製薬会社とペットフードメーカーの戦略的提携により、医学的治療と栄養サポートを組み合わせた統合治療ソリューションの開発が促進されています。

動物用GERD市場の成長を促進する主な要因は何か？

動物性胃食道逆流症（GERD）市場の成長は、ペット飼育率の上昇、動物ヘルスケアへの支出の増加、コンパニオンアニマル・ウェルネスの重視の高まりなど、いくつかの要因によって牽引されています。プレミアムペットヘルスケアサービスや予防医療に対する消費者の嗜好の変化は、GERDのような消化器疾患に対する高度な治療オプションの需要を促進しています。さらに、特に新興市場における動物病院やクリニックの拡大が、診断・治療ソリューションへのアクセスを向上させています。また、競走馬や作業犬などのパフォーマンス・アニマルにおけるGERDの罹患率の増加も市場の成長に寄与しており、飼い主は最適な健康とパフォーマンスを維持するために専門的な治療を求めています。動物用医薬品、診断ツール、栄養学の継続的な進歩により、動物用GERD市場は持続的な成長を遂げる態勢が整っており、動物用ヘルスケア分野の業界利害関係者に有利な機会を提供しています。

セグメント

タイプ（治療タイプ、診断タイプ、その他のタイプ）、動物タイプ（コンパニオンアニマル、畜産動物）、モード（OTCモード、処方箋モード）、流通チャネル（オンライン流通チャネル、動物病院・診療所、小売薬局）

調査対象企業の例

• Annamaet Petfoods, Inc.
• Blue Buffalo Co., Ltd.
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals PLC
• Elanco Animal Health, Inc.
• Heska Corporation
• Hill's Pet Nutrition, Inc.
• Merck & Co., Inc.
• Phathom Pharmaceuticals, Inc.
• Sebela Pharmaceuticals Inc.
• Vetoquinol S.A.
• Zoetis, Inc.

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Animal Gastroesophageal Reflux Disease Market to Reach US$4.8 Billion by 2030

The global market for Animal Gastroesophageal Reflux Disease estimated at US$3.2 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Treatment Type, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Diagnostics Type segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$880.2 Million While China is Forecast to Grow at 10.7% CAGR

The Animal Gastroesophageal Reflux Disease market in the U.S. is estimated at US$880.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$996.9 Million by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Animal Gastroesophageal Reflux Disease Market - Key Trends & Drivers Summarized

Why Is Gastroesophageal Reflux Disease Becoming a Growing Concern in Animals?

The increasing prevalence of gastroesophageal reflux disease (GERD) in companion animals and livestock is becoming a significant concern among veterinarians and pet owners alike. Changes in dietary habits, rising obesity rates in pets, and the growing trend of humanizing pet diets have led to an increase in acid reflux cases in animals, particularly among dogs, cats, and horses. GERD in animals often results from the weakening of the lower esophageal sphincter, leading to acid regurgitation, discomfort, and long-term esophageal damage if left untreated. With the growing awareness about pet health and wellness, there is a surge in demand for effective diagnostic and therapeutic solutions to manage GERD symptoms. Advances in veterinary diagnostics, such as endoscopy and imaging techniques, are enabling early detection and improved treatment outcomes. Additionally, pet owners are increasingly seeking non-invasive and long-term management solutions, further driving the market for specialized medications, dietary supplements, and lifestyle modifications.

How Are Technological Advancements Influencing GERD Diagnosis and Treatment?

The rapid advancements in veterinary healthcare technology are revolutionizing the diagnosis and treatment of gastroesophageal reflux disease in animals. Modern diagnostic tools, including pH monitoring systems, radiography, and esophageal manometry, are enhancing veterinarians' ability to accurately diagnose GERD and develop personalized treatment plans. The growing adoption of minimally invasive procedures such as laparoscopic fundoplication in companion animals is improving treatment outcomes and reducing recovery times. Furthermore, the development of advanced pharmaceuticals, including proton pump inhibitors (PPIs), H2 receptor antagonists, and prokinetic agents, is providing more effective and targeted relief for GERD symptoms. Nutritional advancements, such as specialized diets formulated to minimize acid production and optimize digestive health, are also playing a crucial role in long-term disease management. These technological advancements are making GERD treatment more accessible and efficient, catering to the needs of both pet owners and commercial livestock producers.

What Challenges and Opportunities Exist in the Animal GERD Market?

Despite the promising growth prospects, the animal GERD market faces several challenges, including limited awareness about the condition, high treatment costs, and the lack of standardized treatment protocols across veterinary practices. Many pet owners and livestock farmers are unaware of the symptoms and long-term implications of GERD, leading to underdiagnosis and delayed treatment interventions. Additionally, the costs associated with advanced diagnostic procedures and long-term pharmaceutical treatments can be prohibitive for some pet owners, limiting market penetration. However, these challenges present significant opportunities for market growth, particularly through educational initiatives aimed at raising awareness about GERD symptoms and preventive measures. The growing emphasis on holistic pet wellness and preventive healthcare is creating demand for probiotic supplements, natural digestive aids, and functional foods that support gastrointestinal health. Furthermore, strategic collaborations between veterinary pharmaceutical companies and pet food manufacturers are fostering the development of integrated treatment solutions that combine medical therapy with nutritional support.

What Are the Key Factors Driving Growth in the Animal GERD Market?

The growth in the Animal Gastroesophageal Reflux Disease (GERD) market is driven by several factors, including the rising pet ownership rates, increased spending on veterinary healthcare, and the growing emphasis on companion animal wellness. The shift in consumer preferences towards premium pet healthcare services and preventive care is fueling demand for advanced treatment options for digestive disorders such as GERD. Additionally, the expansion of veterinary clinics and pet hospitals, particularly in emerging markets, is improving access to diagnostic and therapeutic solutions. The increasing incidence of GERD in performance animals, such as racehorses and working dogs, is also contributing to market growth, as owners seek specialized treatments to maintain optimal health and performance. With the continued advancements in veterinary pharmaceuticals, diagnostic tools, and nutrition science, the animal GERD market is poised for sustained growth, offering lucrative opportunities for industry stakeholders across the veterinary healthcare spectrum.

SCOPE OF STUDY:

The report analyzes the Animal Gastroesophageal Reflux Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Treatment Type, Diagnostics Type, Other Types); Animal Type (Companion Animals, Livestock Animals); Mode (OTC Mode, Prescription Mode); Distribution Channel (Online Distribution Channel, Veterinary Hospitals and Clinics, Retail Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Annamaet Petfoods, Inc.
• Blue Buffalo Co., Ltd.
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals PLC
• Elanco Animal Health, Inc.
• Heska Corporation
• Hill's Pet Nutrition, Inc.
• Merck & Co., Inc.
• Phathom Pharmaceuticals, Inc.
• Sebela Pharmaceuticals Inc.
• Vetoquinol S.A.
• Zoetis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Animal Gastroesophageal Reflux Disease - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Awareness Among Veterinarians and Pet Owners Throws the Spotlight on Animal Gastroesophageal Reflux Disease (GERD) as a Growing Health Concern
  • Increasing Incidence of Digestive Disorders in Companion Animals Propels Demand for GERD Diagnosis and Treatment Solutions
  • Expansion of the Veterinary Pharmaceutical Industry Spurs Innovation in Anti-Reflux Medications for Animals
  • Growing Preference for Non-Invasive Diagnostic Techniques Strengthens Business Case for Advanced Imaging and Endoscopy in Veterinary GERD Diagnosis
  • Surging Demand for Specialized Veterinary Diets Drives Growth of GERD-Specific Nutritional Solutions
  • Rising Adoption of Prescription-Only Proton Pump Inhibitors (PPIs) and H2 Receptor Antagonists Expands the Market for Animal GERD Treatments
  • Increasing Availability of Gastroprotective Supplements Generates Demand for Natural and Holistic GERD Management in Pets
  • Regulatory Oversight on Long-Term Use of Acid-Suppressing Medications Influences Product Development in the Veterinary GERD Market
  • Growing Trend of Pet Humanization and Premium Healthcare Spending Propels Investments in GERD Research and Treatment Innovations
  • Rising Cases of Obesity-Related Digestive Disorders in Companion Animals Sustain Growth of GERD-Targeted Therapeutics
  • Expansion of Telemedicine and Online Veterinary Consultations Enhances Accessibility of GERD Treatment for Pet Owners
  • Increasing Role of Veterinary Gastroenterology Specialists Strengthens Market for Advanced GERD Diagnosis and Management
  • Surging Demand for Functional and Easily Digestible Pet Foods Drives Innovation in GERD-Friendly Animal Diets
  • Fluctuations in Regulatory Guidelines for Animal Digestive Health Drugs Shape Market Strategies for Veterinary Pharmaceutical Companies
  • Advancements in Microbiome Research and Probiotic Formulations Open New Opportunities for Natural GERD Treatment in Animals
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Animal Gastroesophageal Reflux Disease Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Animal Gastroesophageal Reflux Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Treatment Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Treatment Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Treatment Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Diagnostics Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Diagnostics Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for OTC Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for OTC Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for OTC Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Prescription Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Prescription Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Prescription Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• JAPAN
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• CHINA
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• EUROPE
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Animal Gastroesophageal Reflux Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• FRANCE
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• GERMANY
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• INDIA
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030
• AFRICA
  • Animal Gastroesophageal Reflux Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Animal Gastroesophageal Reflux Disease by Type - Treatment Type, Diagnostics Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Type - Percentage Breakdown of Value Sales for Treatment Type, Diagnostics Type and Other Types for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Animal Gastroesophageal Reflux Disease by Distribution Channel - Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Online Distribution Channel and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Animal Gastroesophageal Reflux Disease by Animal Type - Companion Animals and Livestock Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Animal Gastroesophageal Reflux Disease by Mode - OTC Mode and Prescription Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Animal Gastroesophageal Reflux Disease by Mode - Percentage Breakdown of Value Sales for OTC Mode and Prescription Mode for the Years 2015, 2025 & 2030

IV. COMPETITION